BioSpace News Archive

Policy

CMA pleased Premiers unite in making health care a priority in Canada

The Council of the Federation meeting in Toronto, Canada’s First Ministers placed our health care system where it belongs: at top of the agenda.

December 2, 2019
·
1 min read
Astellas Presents New Data on XOSPATA® (gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting

Emerging mutations in patients with treatment resistance, from Phase 3 ADMIRAL study, will be focus of oral presentation

December 2, 2019
·
13 min read
Business

Hemostemix Announces Appointment of Director and Postponement of Annual and Special Meeting

Hemostemix Inc. announces the appointment of Mr. Bryson Goodwin as a director of the Company effective December 2, 2019, subject to customary TSX Venture Exchange approval.

December 2, 2019
·
4 min read
Business

Following Two Novartis Deals, IFM Therapeutics Launches Third Subsidiary and Incubator

IFM Therapeutics is launching its third subsidiary this year with a focus on developing next-generation small molecule immunotherapies for inflammatory diseases and cancers.

December 2, 2019
·
3 min read
·
Alex Keown
Business

Kodiak Sciences Inks Royalty-Based R&D Development Deal for $225 Million

Under the terms of the deal with BBA, BBA acquired a capped 4.5% royalty on net sales of KSI-301 that will be paid upon marketing approval.

December 2, 2019
·
2 min read
·
Mark Terry
ASLAN Skyrockets on Preliminary Atopic Dermatitis Data

ASLAN announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of ASLAN004, which is aimed at moderate-to-severe atopic dermatitis.

December 2, 2019
·
2 min read
·
Alex Keown
Biotech Beach

OncoSec Disputes Alpha Holdings’ Claims Regarding Pending Acquisition from CGP

In its announcement today, OncoSec said the deal is pivotal to the company’s future. It claimed that South Korea-based Alpha Holdings, which has about 15% of the company’s stock, has been making “false and misleading statements” as it urges shareholders to oppose the deal.

December 2, 2019
·
2 min read
·
Alex Keown
Business

Communicating Diversity and Inclusion: 5 Life Sciences Companies Who Are Nailing It

Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.

December 2, 2019
·
5 min read
·
Dana Dunbar, Career Branding Strategist
Career Advice

Landing a Job Offer: How to Overcome Objections During an Interview

Be ready by anticipating and countering objections the employer might raise.

December 2, 2019
·
4 min read
·
Katharine Hansen, PhD